Concepedia

James V. Pivnichny

JV

28

Publications

1.3K

Citations

19

H-Index

1983

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

United States Military Academy

United States Army Medical Research Institute of Infectious Diseases

James V. Pivnichny is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, medicine, and drug discovery.

Top concepts

Publications per year

1983–2011

28

Publications

28

Anthrax lethal factor inhibition

Wesley L. Shoop, Y. XIONG, Judyann Wiltsie et al. · Proceedings of the National Academy of Sciences · 2005 · 176 citations · Full text

Liquid chromatographic determination of ivermectin in animal plasma with trifluoroacetic anhydride and N-methylimidazole as the derivatization reagent

P. De Montigny, Jung-Sook K. Shim, James V. Pivnichny · Journal of Pharmaceutical and Biomedical Analysis · 1990 · 174 citations

, , +12

Potent, orally absorbed glucagon receptor antagonists

Stephen E. de Laszlo, Candice Hacker, Bing Li et al. · Bioorganic & Medicinal Chemistry Letters · 1999 · 169 citations · Full text

, , +5

Design and synthesis of potent, orally bioavailable dihydroquinazolinone inhibitors of p38 MAP kinase

John E. Stelmach, Luping Liu, Sangita B. Patel et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 81 citations · Full text

, , +10

Effect of Signal Interference from Dosing Excipients on Pharmacokinetic Screening of Drug Candidates by Liquid Chromatography/Mass Spectrometry

Xinchun Tong, Junying Wang, Song Guo Zheng et al. · Analytical Chemistry · 2002 · 74 citations

, , +19

Rows per page

1–5 of 28